|
Re: Zenith Epigentics and Resverlogix update 22 Jan 2018
|
2
|
Resverlogix Corp.
|
Feb 01, 2018 11:39AM
|
|
Updated Analyst Report from Marcel Wijma, Van Leeuwenhoeck Institute
|
10
|
Resverlogix Corp.
|
Feb 02, 2018 11:00AM
|
|
Apabetalone mention in new article on evolving lipid lowering therapies
|
1
|
Resverlogix Corp.
|
Feb 02, 2018 11:17AM
|
|
Getting amyloid beta antibodies across the BBB.....
|
4
|
BIOASIS TECHNOLOGIES INC
|
Feb 02, 2018 11:25AM
|
|
Re: Just a questiom
|
2
|
Resverlogix Corp.
|
Feb 03, 2018 08:39AM
|
|
Re: Pfizer vs J&J - Nonmetastatic prostate cancer
|
5
|
Zenith Epigenetics
|
Feb 06, 2018 11:48AM
|
|
Re: Pfizer vs J&J - Nonmetastatic prostate cancer
|
5
|
Zenith Epigenetics
|
Feb 06, 2018 02:19PM
|
|
Resverlogix on schedule to present at BIO CEO Tuesday 2/13
|
1
|
Resverlogix Corp.
|
Feb 06, 2018 04:58PM
|
|
Re: We Need The Futility Analysis
|
2
|
Resverlogix Corp.
|
Feb 06, 2018 05:02PM
|
|
Re: NR: Resverlogix Highlights Key Accomplishments and 2018 Targets...
|
6
|
Resverlogix Corp.
|
Feb 08, 2018 08:54AM
|
|
Re: Update
|
5
|
Resverlogix Corp.
|
Feb 13, 2018 08:54PM
|
|
Marching on to March events
|
2
|
Resverlogix Corp.
|
Feb 14, 2018 05:46PM
|
|
Marching on to March events
|
1
|
Zenith Epigenetics
|
Feb 14, 2018 05:50PM
|
|
Re: Marching on to March events
|
1
|
Resverlogix Corp.
|
Feb 14, 2018 08:48PM
|
|
Re: Marching on to March events
|
5
|
Zenith Epigenetics
|
Feb 15, 2018 04:30PM
|
|
Re: Marching on to March events
|
5
|
Zenith Epigenetics
|
Feb 15, 2018 04:38PM
|
|
Re: Story time with tada
|
3
|
Resverlogix Corp.
|
Feb 15, 2018 08:47PM
|
|
Re: Update
|
3
|
Resverlogix Corp.
|
Feb 16, 2018 02:46PM
|
|
3600 patient years
|
8
|
Resverlogix Corp.
|
Feb 16, 2018 03:27PM
|
|
Now a Phase 2 trial
|
5
|
Zenith Epigenetics
|
Feb 16, 2018 04:33PM
|
